brain cancer

In an advance toward better treatments for the most serious form of brain cancer, scientists in Illinois are reporting development of the first nanoparticles that seek out and destroy brain cancer cells without damaging nearby healthy cells.

(American Chemical Society) In an advance toward better treatments for the most serious form of brain cancer, scientists in Illinois are reporting development of the first nanoparticles that seek out and destroy brain cancer cells without damaging nearby healthy cells.

The study is scheduled for the Sept. 9 issue of ACS' Nano Letters, a monthly journal.

The Hedgehog signaling pathway is involved in a preliminary study and case report describing positive responses to an experimental anticancer drug in a majority of people with advanced or metastatic basal cell skin cancers.

One patient with the most common type of pediatric brain cancer, medulloblastoma, also showed tumor shrinkage.

Scientists have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to soft biological material.

(DOE/Argonne National Laboratory) Scientists from the US Department of Energy's Argonne National Laboratory and the University of Chicago's Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to soft biological material.

Researchers have uncovered a new way to scan brain tumors and predict which ones will be shrunk by the drug Avastin -- before the patient ever starts treatment.

By linking high water movement in tumors to positive drug response, the scientists predicted with 70 percent accuracy which patients' tumors were the least likely to grow six months after therapy.

Pinpointing the genes involved in human brain cancer can be like looking for a needle in a haystack, and sometimes the needle you find may not be the right one.

Scientists have found that a deficiency in a key tumor suppressor gene in the brain leads to the most common type of adult brain cancer.

The study, conducted in mice that mimic human cancer, points the way to more effective future treatments and a way to screen for the disease early.

An experimental compound showed good results for months in patients with glioblastoma multiforme, researchers say.

After undergoing other treatments, including surgery, chemotherapy and radiation, the trial patients' brain cancer had begun to grow again prior to starting on the current clinical trial.

An unlikely multidisciplinary scientific collaboration has discovered that an electronic nose developed for air quality monitoring on Space Shuttle Endeavour can also be used to detect odor differences in normal and cancerous brain cells.

The results of the pilot study open up new possibilities for neurosurgeons in the fight against brain cancer.